.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Covington
Fuji
Novartis
Argus Health
Merck
Cantor Fitzgerald
Healthtrust
Citi
Johnson and Johnson

Generated: January 24, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Estrogens, Non-Steroidal

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers SquibbSTILBETINdiethylstilbestrolTABLET, DELAYED RELEASE;ORAL004056-011Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
Bristol Myers SquibbSTILBETINdiethylstilbestrolTABLET;ORAL004056-009Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
LillyDIETHYLSTILBESTROLdiethylstilbestrolTABLET, DELAYED RELEASE;ORAL004039-006Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
Bristol Myers SquibbSTILBESTROLdiethylstilbestrolINJECTABLE;INJECTION004056-005Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
LillyDIETHYLSTILBESTROLdiethylstilbestrolTABLET, DELAYED RELEASE;ORAL004039-002Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
TablicapsSTILBESTROLdiethylstilbestrolTABLET;ORAL083002-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
TablicapsSTILBESTROLdiethylstilbestrolTABLET, DELAYED RELEASE;ORAL083005-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
LillyDIETHYLSTILBESTROLdiethylstilbestrolTABLET;ORAL004041-003Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
Bristol Myers SquibbSTILBETINdiethylstilbestrolTABLET;ORAL004056-010Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
Sanofi Aventis UsTACEchlorotrianiseneCAPSULE;ORAL011444-001Approved Prior to Jan 1, 1982DISCNNoNo➤ Subscribe➤ Subscribe➤ Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Julphar
AstraZeneca
Fish and Richardson
Covington
Fuji
Accenture
Queensland Health
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot